Hypertrophic Cardiomyopathy: The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family Screening
The proband's age at hypertrophic cardiomyopathy diagnosis was associated with clinical and genetic findings, but the cardiovascular death and the yield of family screening were similar across all ages at diagnosis, supporting the presently recommended follow-up and family screening irrespective of the proband's age at diagnosis.
Authors
- Anna Axelsson Raja (ORCID: https://orcid.org/0000-0001-8665-3309)
- Alex Hørby Christensen (ORCID: https://orcid.org/0000-0002-6855-1496)
- Martin Snoer (ORCID: https://orcid.org/0000-0001-7188-629X)
- Christoffer Rasmus Vissing (ORCID: https://orcid.org/0000-0002-0834-206X)
- Jens Jakob Thune (ORCID: https://orcid.org/0000-0002-3621-3775)
- Emil D. Bartels (ORCID: https://orcid.org/0000-0002-8290-5772)
- Henning Bundgaard (ORCID: https://orcid.org/0000-0002-0563-7049)
- Elvira Silajdzija (ORCID: https://orcid.org/0009-0001-8873-429X)
- Thilde Olivia Kock (ORCID: https://orcid.org/0000-0001-8240-0363)
- Helen Mills (ORCID: https://orcid.org/0000-0002-3011-0740)
- Lars Juel Andersen
- Emma Basse Christensen (ORCID: https://orcid.org/0000-0002-4526-6107)
Institutions
- University of Copenhagen (DK)
- Frederiksberg Hospital (DK)
- Hvidovre Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Zealand University Hospital (DK)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1161/jaha.125.043711
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00